AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Gain Therapeutics, Inc. Director's Dealing 2021

Mar 18, 2021

34440_dirs_2021-03-17_fb71f79c-484d-47a3-96c6-9ef8458b21d5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gain Therapeutics, Inc. (GANX)
CIK: 0001819411
Period of Report: 2021-03-17

Reporting Person: RICHMAN ERIC I (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	211898	Direct